Simulands designs, produces, and distributes ISO-compliant simulation devices and tools for cardiovascular interventions. Its simulators deliver real haptic responses, procedural imaging guidance, and insights into device performance across different experience levels. Led by CEO Andrea Guidotti, the company supplies physician and field-specialist training solutions. Its clientele includes large MedTech companies such as Abbott, Edwards Lifesciences, and Boston Scientific, as well as emerging startups. The company intends to use the funds to further accelerate commercialization of its solutions. Simulands is headquartered in Zurich, Switzerland.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2023